BVF Inc/il, 10% Owner at Nivalis Therapeutics, Inc. (NVLS), bought 164,817 shares at $2.35 ($385K) on 2017-05-10, disclosed to the SEC on 2017-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.29 | 3,929 | $9K | 2.3% |
| 2 | $2.29 | 14,274 | $33K | 8.5% |
| 3 | $2.29 | 21,797 | $50K | 13.0% |
| 4 | $2.35 | 6,217 | $15K | 3.8% |
| 5 | $2.35 | 22,092 | $52K | 13.5% |
| 6 | $2.35 | 22,092 |
| $52K |
| 13.5% |
| 7 | $2.35 | 33,691 | $79K | 20.6% |
| 8 | $2.35 | 33,691 | $79K | 20.6% |
| 9 | $2.34 | 675 | $2K | 0.4% |
| 10 | $2.34 | 2,565 | $6K | 1.6% |
| 11 | $2.34 | 3,794 | $9K | 2.3% |
| Total | $2.34 avg | 164,817 | $385K | 100% |
| Filing → |
| PNT | SELL | 2023-12-20 | $427.3M | — | Filing → |
| CGEM | BUY | 2022-05-16 | $20.1M | — | Filing → |
| KYMR | BUY | 2022-05-09 | $8.3M | — | Filing → |